Hyderabad-based paediatrician Sivaranjani Santosh, whose eight-year struggle led to a major regulatory change regarding ORS Labeling, is now facing legal issues. Pharma companies have issued a notice claiming she made false, misleading, disparaging, and defamatory comments about their products.
Defamation Notice to Pediatrician After Winning ORS Labeling Fight
This situation arose after the Food Safety and Standards Authority of India (FSSAI) issued an order in October 2025. The order said that no food brand could use the term ‘Oral Rehydration Salts’ or ‘ORS’ unless the formulation strictly followed the standards set by WHO.
A cease and desist notice dated March 16 accuses Dr. Santosh of making defamatory statements on social media. It is about products like ORSL and its rebranded version ERZL. The notice claims that the companies science-based and follow the Food Safety and Standards Act of 2006. It emphasizes that their claims have scientific backing and regulatory approvals.
Regulatory and Legal Context
Regarding ongoing regulatory and legal matters, the notice references a case before the Delhi High Court. The court noted that the products in question ‘not adulterated or unsafe for use’ and that the dispute focused on branding issues.
The notice disputes any claims that past ORS Labeling products sold or that ERZL marketed as an ORS substitute. It states that distributors directed to return or relabel older stock in line with FSSAI guidelines.
Read also: Security Breach at Kerala Secretariat: Trio Claims Google Maps Responsible